Dual antiplatelet therapy after drug-eluting stents--how long to treat?
From the Interventional Cardiology Unit, San Raffaele Scientific Institute (A. Colombo and A. Chieffo), and EMO-GVM Columbus Hospital (A. Colombo) - both in Milan.
Antonio
A
Colombo
Alaide
A
Chieffo
D001241:Aspirin / Q000008:administration & dosage*; D000077144:Clopidogrel; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D008297:Male; D010879:Piperazines / Q000008:administration & dosage*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D000068799:Prasugrel Hydrochloride; D013876:Thiophenes / Q000008:administration & dosage*; D013927:Thrombosis / Q000517:prevention & control*; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives*
D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D013876:Thiophenes; D000077144:Clopidogrel; D000068799:Prasugrel Hydrochloride; D013988:Ticlopidine; D001241:Aspirin